| |
| | Joined: Mar 2002 Posts: 4,918 Likes: 66 OCF Founder Patient Advocate (old timer, 2000 posts) |  OCF Founder Patient Advocate (old timer, 2000 posts)
Joined: Mar 2002 Posts: 4,918 Likes: 66 | Please look at the link at the bottom of this page http://oralcancerfoundation.org/treatment/targeted_therapies.htmAlso it is well documented, and in a recently posted news story on the OCF news site, that the rash response to Erbitux, is, while discomforting, a positive sign that the treatment is effective. In peer reviewed studies, those that had acute response in the form of a rash, also had the greatest success rates with the treatment.
Brian, stage 4 oral cancer survivor. OCF Founder and Director. The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant.
| | |
| Forums23 Topics18,252 Posts197,146 Members13,330 | | Most Online1,788
Jan 23rd, 2025 | | |
|
| |
